Results 211 to 220 of about 560,370 (324)

Research status and frontiers in liver cancer immunotherapy: a bibliometric perspective on highly cited literature. [PDF]

Front Oncol
Su P, Han Y, Yi J, Hou Y, Xiao Y.
europepmc   +1 more source

Cancer immunotherapy comes of age

Nature, 2011
I. Mellman, G. Coukos, G. Dranoff
semanticscholar   +1 more source

Optical Microfiber Biomedical Sensors: Classification, Applications, and Future Perspectives

Advanced Sensor Research, EarlyView.
This review delves deeply into the various types of optical microfiber biosensors, grounded firmly in their fundamental principles, and underscores their indispensable roles in pushing forward biomedical advancements. It examines the latest advancements, challenges faced by these biosensors in practical applications, future directions, breakthroughs ...
Lili Liang, Fei Xie, Li Jin, Bowen Yang, Li‐Peng Sun, Bai‐Ou Guan   +5 more
wiley   +1 more source

P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT

HemaSphere, 2022
O. Albanyan, D. Kalos, J. Kim, R. Faramand, H. Elmariah, A. Mishra, T. Nishihori, L. Perez, M. Nieder, J. Pidala, N. Bejnayan   +10 more
doaj   +1 more source

Multi-omics in immunotherapy research for HNSCC: present situation and future perspectives. [PDF]

NPJ Precis Oncol
Liu XH, Wang GR, Zhong NN, Wang WY, Liu B, Li Z, Bu LL.   +6 more
europepmc   +1 more source

Autologous Peripheral Vγ9Vδ2 T Cell Synergizes with αβ T Cell Through Antigen Presentation and BTN3A1 Blockade in Immunotherapy of Cervical Cancer

Advanced Science, EarlyView.
This study provides proof‐of‐concept evidence showing that through direct killing, antigen presentation, and competitively binding to BTN3A1, Vγ9Vδ2 T cells amplified from cervical cancer (CC) patients can synergize with αβ T cells to exert anti‐CC function both in vitro and in vivo.
Min Wu, Jian Liu, Liting Liu, Yifan Yang, Hong Liu, Long Yu, Haihong Zeng, Shuo Yuan, Ruiyi Xu, Hangyu Liu, Han Jiang, Shen Qu, Liming Wang, Ying Chen, Jingyu Wang, Yuwei Zhang, Shan He, Ling Feng, Junyan Han, Wanjiang Zeng, Hui Wang, Yafei Huang   +21 more
wiley   +1 more source

Exosome-based immunotherapy in hepatocellular carcinoma. [PDF]

Clin Exp Med
Liu H, Wang G, Li Z, Zhang X, Zhang W, Zhang X, Liu F, Gao J.   +7 more
europepmc   +1 more source

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

Nature Reviews Clinical Oncology, 2018
D. Fukumura, Jonas Kloepper, Zohreh Amoozgar, D. Duda, R. Jain   +4 more
semanticscholar   +1 more source

Sustained Vaccine Exposure Elicits More Rapid, Consistent, and Broad Humoral Immune Responses to Multivalent Influenza Vaccines

Advanced Science, EarlyView.
This work presents an injectable polymer‐nanoparticle hydrogel depot platform for delivering multivalent influenza vaccines which induces stronger and more durable immune responses. The technology provides broader protection, including against heterologous and potential pandemic strains (H5N1, H7N9, H9N2), and enhances the effectiveness of commercial ...
Olivia M. Saouaf, Ben S. Ou, Ye Eun Song, Joshua J. Carter, Jerry Yan, Carolyn K. Jons, Christopher O. Barnes, Eric A. Appel   +7 more
wiley   +1 more source

Nomogram based on computed tomography radiomics features and clinicopathological factors to predict the prognosis of patients with non-small cell lung cancer receiving immune checkpoint inhibitor rechallenge. [PDF]

Transl Lung Cancer Res
Zhao J, Li Y, Li R, Yao X, Dong X, Su L, Li Y.   +6 more
europepmc   +1 more source